We have worked hard to provide transparency so that you can see the underlying results. We experienced a slower increase in our cost of funds in the third quarter, although like many banks, we continue to see the shift out of lower-cost deposits into higher cost deposits and we expect that to continue in Q4 and into 2024. In spite of the increase in costs, we continue to be confident that our lower cost deposit portfolio will be a long-term competitive advantage. We have worked very hard to keep our wholesale funding levels at modest levels and we think an efficient balance sheet is in our long -- in our shareholders' long-term interest. Excluding the sale of the shared national credit loans we described in the presentation, core commercial loan growth in Q3 was modest, and we expect it to stay that way for the next few quarters.

We are finding loan demand to be limited as our customers are being cautious in part due to the higher level of interest rates. We also expect consumer and mortgage loan growth in the single digits over the next few quarters. With the pending sale of Eastern Insurance, there is more visibility into the expense profile of the bank on a stand-alone basis. We believe that we have made significant progress on the efficiency goals we set at the time of our IPO in 2020, for both our efficiency ratio and expense to assets ratio and expect further improvement as we combine with Cambridge Trust. Our asset quality metrics continue to be very strong in Q3 with credit losses below 1 basis point and continuing low levels of nonperforming loans. We continue to manage our exposure to the office sector and provide details on the portfolio in the presentation.

Our balance sheet strength continues to be a focus and a source of strength. Both our regulatory and GAAP capital levels are strong relative to requirements, as compared with many of our peers, our loan deposit portfolios are of high quality and our wholesale funding levels at 5% of assets are low. We will continue to look for ways to strengthen the balance sheet even further over time, but believe this strength is a competitive advantage. Looking ahead, we are very excited about the future opportunities as we merge with Cambridge Trust, our enhanced market position, increased scale and capabilities, along with significantly larger wealth management and private banking businesses will provide a stronger platform for future growth in earnings than we have historically had.

We look forward to providing you additional details as we move through the regulatory approval process in closing. As I conclude my remarks, I express my thanks and deepest appreciation to all of our Eastern Insurance Group colleagues for their many contributions to Eastern's overall success and culture over the past 21 years. And as their planned transition to A.J. Gallagher approaches, we send our best wishes for continued success. I have every confidence they will continue to excel leveraging Gallagher's market-leading capabilities and we look forward to partnering with them and serving our mutual clients. And once again, I especially thank Eastern Insurance's President and CEO, Tim Lodge, and his executive team for their many contributions to Eastern and for leading the team through this process.

Finally, I also want to thank our Chief Credit Officer, Dan Sullivan, for his 27 years of service to Eastern as he retires this month and wish him a very happy and healthy retirement. Dan was the architect of our credit process and culture at Eastern, a long-time strength of our company, with delinquency rates, levels of nonperforming loans and net credit losses regularly among the lowest of our peers. Dan joined us in 1996 is our very first Chief Credit Officer when Eastern had just $2.1 billion in assets with 28 branches, helping to lead our transformation from a savings bank to one with a loan portfolio that is now over 70% commercial, quite a legacy. I'm delighted to share that Matthew Osborne, former Head of our commercial real estate and community development lending teams and a 25-year veteran at Eastern has assumed Dan's role as our Chief Credit Officer, creating a seamless transition for our teams.

As a result, Greg Vasconi, who leads our middle market lending and international banking teams will become our Chief Commercial Banking Officer. Each of these promotions is representative of long times thoughtful succession planning as well as the tremendous talent and bench strength within our organization. Once again, we are pleased with our results this quarter and feel very confident regarding Eastern's future growth and performance. As always, most of the credit for this goes to my 2,100 colleagues, who continue to ensure that Eastern remains the strong and reliable financial and community partner we have been for the past 25 years, as well as to our customers and community partners for their business, support and partnership. And with that, I'll turn it over to Jim.

Jim Fitzgerald: Great. Thank you, Bob, and good morning, everyone. As Bob mentioned, it was a very busy third quarter for us with the insurance transaction and the merger with Cambridge announced together in mid-September. Both are very important strategic transactions for us and combined will lead to a stronger balance sheet, enhanced market share and a platform for future earnings growth that we are very excited about. As I mentioned on the call in September, the transactions do create some short-term noise in our results. The sale of the insurance operations requires us to account for Eastern Insurance as a discontinued operation and to restate our prior period results accordingly. In some ways, this is helpful as it provides an early view of what we will look like going forward without Eastern Insurance, although we recognize it's a change from what we've presented historically.

We provide details on the results for Eastern Insurance that are contained in discontinued operations on Page 7 of the earnings presentation. In addition to the core results, there were $10.7 million of transaction-related charges that occurred in Q3. Excluding those costs, EIG's results were in line with expectations. One reminder is that discontinued operations are not included in our operating net income, which makes comparisons with the overall expectations difficult. In addition, the insurance transaction allowed us to eliminate a tax valuation allowance of approximately $15 million that we set up as part of the security sale in Q1. Although this was very positive and an additional economic benefit of the transaction, it's a onetime event.

I'll provide some comments on our tax rate later in my remarks. As Bob mentioned, both transactions are progressing very well. We expect the sale of EIG to occur next week as anticipated and have submitted all the regulatory applications for approval for the Cambridge merger. I'll follow up with some specific comments on both transactions when I discuss our outlook. We are very pleased to announce a 10% increase in our dividend from $0.10 to $0.11 per share, which is payable in December. We have a high degree of confidence in our strategic direction and our operating earnings and believe this dividend reflects that confidence. Starting with some highlight. Net income for the quarter was $59.1 million or $0.36 per share. Operating earnings were $52.1 million or $0.32 per share.

Net income includes both a loss of $4.4 million from discontinued operations and a tax benefit of $16.2 million, which was driven by the elimination of the $15 million tax valuation allowance I mentioned. Also, as I mentioned, the loss on discontinued operations is due to transaction costs incurred in the sale of Eastern Insurance. The net interest margin of 2.77% was relatively stable quarter-to-quarter, down just 3 basis points from Q2. Deposit costs were well contained, up 11 basis points in the quarter from 1.22% to 1.33% and interest-bearing deposit costs were up 18 basis points from 1.71% to 1.89%. Total assets declined approximately $400 million from June 30, due primarily to declines in cash and securities. Capital levels remain very strong with a CET1 ratio of 16% and a fully marked tangible equity to tangible assets ratio, which includes unrealized losses on HTM securities of 8.5%.

In the quarter, core commercial loan growth, which excludes the sale of shared national credits I'll discuss shortly, was just under 2%, which was down from earlier in the year, but consistent with our expectations. Residential mortgage growth was 6% annualized in the quarter and consumer loan growth was 2%. Asset quality remained very strong with essentially no net loan charge-offs and NPLs were up from Q2 but still a very low 34 basis points of loans. I'll have more to add on the details behind these headlines as I go through my remarks. Starting with the balance sheet. Assets declined by $400 million during the quarter to $21.1 billion. Cash declined $265 million as we lowered the amount of on-balance sheet cash we have been holding. Securities were lower by $268 million due to runoff and lower market values and loans were down by $54 million due to the sale of the shared national credit loans I just mentioned.

Deposits were down $757 million due to reductions in broker deposits of $306 million, the maturity of a $230 million noncore term deposit from the Century acquisition and a seasonal decrease in municipal deposits of $375 million. Borrowings increased by $364 million to replace maturing brokered CDs. We made this shift to short-term borrowings to more easily facilitate the pay down of wholesale funding when we receive the cash from the EIG sale next week. Shareholders' equity declined by $80 million due to a decrease in AOCI, partially offset by retained earnings. And book value ended the quarter at $13.87 per share and tangible book value ended the quarter at $10.14 per share. Net income was $59.1 million or $0.36 per diluted share and operating net income was $52.1 million or $0.32 per diluted share.

As I mentioned, there are significant number of items that created noise and I will try to point them out in my review. Net interest income was $137.2 million, down $4.4 million from the prior quarter. As I mentioned, the net interest margin was 2.77%, which was down 3 basis points from Q2. The decline in net interest income was primarily due to the reduced size of the balance sheet. As we outlined on Page 8, loan yields were up 16 basis points on average in the quarter while total interest earning assets were up 10 basis points, in part due to the reduction in cash I mentioned earlier. Interest-bearing liability costs were up 20 basis points and deposit costs were up 11 basis points as well. We provided a waterfall chart on Page 8 to show the changes from Q2 to Q3, and we also show the 5-quarter trend for the net interest margin.

The loan loss provision was $7.3 million and included specific reserves for 3 nonperforming office loans that I will describe in more detail later in my remarks. Noninterest income was $19.2 million and $20.7 million on an operating basis. This excludes the insurance revenue that's been reclassified to discontinued operations. As is outlined on Page 9, deposit service charges, trust, debit card and other fees are in line with last quarter and combined are up 8% from the prior year quarter. We took the opportunity to sell approximately $200 million of shared national credit loans out of our commercial loan portfolio at a $2.7 million loss during the quarter. The sale of these loans triggered a release of associated reserves bringing the economic loss close to breakeven.

The reason for the sale is very straightforward. We expect funding conditions to remain tight for the foreseeable future and this preserves some balance sheet capacity for our core lending customers. One additional note on this is that the loss is included in our operating results. As you can see on Page 9 of the presentation, excluding this loss, operating noninterest income was essentially the same as Q2. Noninterest expense was $101.6 million or $98.7 million on an operating basis. As I've mentioned a few times, this excludes the expenses of Eastern Insurance, which were moved to discontinued operations. Q3's operating expense of $98.7 million is very similar to Q2 and an increase of 2% over the prior year, as we continue to focus on efficiency.

To repeat one of the comments Bob made, we have made significant progress on our expense efficiency since the IPO in 2020 and we look forward to creating more efficiencies as we merge with Cambridge in 2024. Our tax line includes several components from the securities loss on sale earlier in the year. As I mentioned, the insurance sale allows us to eliminate a $15 million valuation allowance we had set up back in Q1. Also because year-to-date, we are in a loss position, there are limited taxes on our overall results as well. When we record the insurance gain in Q4, we will be applying a higher tax rate, both on the gain and our operating results. I'll add some more comments on our taxes when I go over our outlook. Switching gears to asset quality.

We continue to be very focused on the challenges in commercial real estate in general and the office sector, in particular but we remain very confident in our long-term approach to dealing with customers, which serve us well throughout the rest of this cycle in all economic cycles. Saw an increase in nonperforming loans from $31 million to $48 million in the quarter. As a percentage of loans, the increase was from 22 basis points to 34 basis points. These are very low levels that we expect to see normalized higher up over time. Included in the increase were 3 investor office properties that totaled $26 million. We are working with the borrowers and expect these loans to move through the sale process over the next several quarters. Included in the provision for the quarter of $7.3 million, were specific reserves against these 3 loans to cover our expected losses from the sale process.

Actual charge-offs for the quarter were less than 1 basis point. Aside from the office portfolio, all other loan categories are performing well and our credit metrics are in a very strong position. We updated the office portfolio presentation and included as Page 15 in the presentation and added some data that we haven't provided previously. We have $96 million of criticized and classified assets in the office portfolio, of which $26 million are the 3 new NPLs I just mentioned. Additionally, we have $100 million of loans that will mature before Q4 of '24 or approximately 14% of all investor office CRE. The $100 million of loan maturities is also a reasonable proxy for the annual maturities for the years after 2024 as well. Our expectations for the office portfolio remain the same.

It's a challenging environment for all office properties, but especially those in urban markets and particularly those in the Boston Financial District. We will work with our borrowers as they work through the challenges and try and get to the other side. If they can't or won't do that, we'll protect our interest and manage to work out to optimize our proceeds. As I mentioned, we provided specific reserves for the 3 office properties this quarter and we'll report on the progress of those assets as we move through the next few quarters. We'll also continue to report on the level of criticized and classified assets in the office portfolio as well. Turning to our outlook. We are looking forward to closing the insurance transaction next week. It's a very significant milestone, and we anticipate the gain to be approximately $260 million or in line with our prior guidance.

We expect to have a 28% tax rate against the gain and also for our Q4 results. Typically, Q4 is a seasonally low period for funding in our municipal business and leads to higher levels of wholesale funding requirements as we experienced in 2022. This will put additional pressure on our net interest margin and net interest income in Q4 and early 2024. We expect the net interest margin to decline in Q4 to the mid-260s and for net interest income to be between $127 million and $132 million. We expect operating noninterest income to be very similar to Q3 and to be in a range between $22 million and $25 million. We expect operating noninterest expenses to be $4 million to $5 million higher in Q4 due to higher marketing costs, some timing issues and some typical year-end items.

Similar to this quarter, we expect to prioritize the strength of the balance sheet as we move forward. We continue to expect modest loan growth in Q4 and we will seek to keep wholesale borrowings as low as practical and to keep our capital levels robust. We believe focusing on our balance sheet strength will position us well for when the environment improves. As noted in our earnings release, our share repurchase authorization expired in the third quarter and there are restrictions on our ability to repurchase shares while the merger with Cambridge is pending. We look forward to seeking another repurchase authorization when allowable and also look forward to resuming our share repurchase activity. In closing, we believe we have a major opportunity in front of us with the Cambridge Trust merger.

The combined company is expected to produce 20% earnings accretion in a very challenging environment, have significant levels of both regulatory and GAAP capital. A leading market share in some very attractive markets and a fully marked acquired balance sheet. The IRR for the transaction is 20%. We are very focused on the execution of the merger including the required regulatory and shareholder approvals, and we report next quarter with an update as we approach the closing. Thank you very much. And Julie, you can open up the lines for questions.

Operator: [Operator Instructions] Your first question comes from Mark Fitzgibbon from Piper Sandler. Please go ahead.

See also 12 Best Places to Retire in Greece and Deep Value Stocks ETFs: Top 10 Picks.

To continue reading the Q&A session, please click here.